Versant Capital Management’s Arcus Biosciences RCUS Stock Holding History

Versant Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11K	Hold	358	–	–	﹤0.01%	2201
2026 Q1	$7.73K	Hold	358	–	–	﹤0.01%	2242
2025 Q4	$8.53K	Hold	358	–	–	﹤0.01%	2068
2025 Q3	$4.87K	Hold	358	–	–	﹤0.01%	2216
2025 Q2	$2.91K	Sell	358 -415	-54%	-$3.54K	﹤0.01%	2310
2025 Q1	$6.07K	Buy	773 +525	+212%	+$6.09K	﹤0.01%	1960
2024 Q4	$3.69K	Buy	248 +9	+4%	+$147	﹤0.01%	1900
2024 Q3	$3.65K	Buy	239 +100	+72%	+$1.58K	﹤0.01%	1384
2024 Q2	$2.12K	Buy	+139	New	+$2.24K	﹤0.01%	1494
2023 Q1	–	Sell	-10	Closed	-$207	–	1799
2022 Q4	$207	Sell	10 -2	-17%	-$55	﹤0.01%	1597
2022 Q3	$0	Sell	12 -1	-8%	-$26	﹤0.01%	1608
2022 Q2	$0	Hold	13	–	–	﹤0.01%	1608
2022 Q1	$0	Hold	13	–	–	﹤0.01%	1593
2021 Q4	$1K	Hold	13	–	–	﹤0.01%	1330
2021 Q3	$0	Hold	13	–	–	﹤0.01%	1564
2021 Q2	$0	Hold	13	–	–	﹤0.01%	1572
2021 Q1	$0	Hold	13	–	–	﹤0.01%	1588
2020 Q4	$0	Buy	+13	New	+$315	﹤0.01%	1497

Other funds holding RCUS

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Versant Capital Management's RCUS Position: Q2 2026 in Review

Versant Capital Management held its Arcus Biosciences (RCUS) position steady in Q2 2026 at 358 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #2201.

Versant Capital Management first reported a position in RCUS in Q4 2020 and has held it in 18 quarters since. 17 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

Versant Capital Management held 358 shares of Arcus Biosciences worth $11K as of Q2 2026.
Versant Capital Management left its Arcus Biosciences share count unchanged in Q2 2026.
Arcus Biosciences made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2201 holding.
Versant Capital Management first reported a position in Arcus Biosciences in Q4 2020 and has held it in 18 quarters since.
17 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.